Blog
RSS FeedPosted by Michael Wonder on 21 Nov 2018
Request for proposals - supply of various vaccines and influenza vaccines
20 November 2018 - PHARMAC invites proposals for the supply of various vaccines and influenza vaccines in New Zealand. ...
Posted by Michael Wonder on 19 Nov 2018
Pharma ignores the squabbling and prepares for a hard Brexit
19 November 2018 - Costs are irrecoverable in industry that has to plan for all possible scenarios. ...
Posted by Michael Wonder on 19 Nov 2018
Which databases should be used to identify studies for systematic reviews of economic evaluations?
16 November 2018 - This study investigated which databases and which combinations of databases should be used to identify economic evaluations ...
Posted by Michael Wonder on 19 Nov 2018
Innovative skin cancer drug available on Cancer Drugs Fund
19 November 2018 - Patients with a type of advanced skin cancer have a new treatment option as pembrolizumab, also known ...
Posted by Michael Wonder on 19 Nov 2018
Poor value sees younger people dropping private health insurance
18 November 2018 - Younger people are ditching private health cover or not taking up cover in the first place, ...
Posted by Michael Wonder on 17 Nov 2018
BHA, ABPI welcome UK’s EU withdrawal agreement
16 November 2018 - The Brexit Health Alliance has welcomed the agreement on the terms of the UK’s withdrawal from ...
Posted by Michael Wonder on 16 Nov 2018
NICE recommends cutting-edge therapy for young people with blood cancer
16 November 2016 - NICE has recommended a pioneering cancer treatment, CART-cell therapy, for people under the age of 25 with ...
Posted by Michael Wonder on 15 Nov 2018
German health minister calls for faster adoption of biosimilar drugs
14 November 2018 - Germany’s health minister Jens Spahn has called for faster adoption of cheaper copies of biotech drugs ...
Posted by Michael Wonder on 15 Nov 2018
Final NICE green light for Pfizer’s Mylotarg
15 November 2018 - Cost regulators for the NHS in England and Wales have now published final guidelines recommending Mylotarg, ...
Posted by Michael Wonder on 15 Nov 2018
Lowering the price of new drugs comes with too high a cost — Canadians' health
14 November 2018 - Ottawa wants to apply new price regulations, which will only cut manufacturer profits and deter the introduction ...
Posted by Michael Wonder on 15 Nov 2018
'Death sentence': One-in-a-million rare cancers get the 'sorting hat' treatment
13 November 2018 - For people with the rarest of cancers, the hope of survival or an effective treatment can ...
Posted by Michael Wonder on 14 Nov 2018
My Health Record opt-out deadline extended after system crash
14 November 2018 - Federal Health Minister Greg Hunt has agreed to extend the My Health Record opt-out deadline, after ...
Posted by Michael Wonder on 13 Nov 2018
Canada's HTA agency releases report on international biosimilar policies
8 November 2018 - The Canadian Agency for Drugs and Technologies in Health (CADTH), the Canadian entity responsible for health ...
Posted by Michael Wonder on 13 Nov 2018
ICR responds to NICE decision on olaparib for women with advanced ovarian cancer
9 November 2018 - NICE has announced today its decision not to recommend olaparib for women with advanced ovarian cancer ...
Posted by Michael Wonder on 12 Nov 2018
PBAC shows no propensity to support Amgen's innovative method of analysis
12 November 2018 - Amgen's recent submission for blinatumomab (Blincyto) treatment of patients with B-cell precursor acute lymphoblastic leukaemia in haematological ...